homenewsfunds managedportfolioabout uscontacting usconfidentialityinvestorsresearch
  Since 1993, ETCapital has invested in over 40 high growth businesses in the greater Cambridge region  

 

ADCT

ADC Therapeutics is a biopharmaceuticals company developing a pipeline of anti-cancer products based on antibody drug conjugation technology developed by Spirogen Limited.

 
 
Bango

Bango is a mobile payments and analytics service provider. Bango floated on AIM on 30 June 2005 - EPIC code BGO

 
 
CDT

Cambridge Display Technology develops and supplies proprietary materials for OLED displays based on technology developed at the Cavendish Laboratory. CDT floated on NASDAQ in December 2004 and has since been acquired by Sumitomo Chemcial Co Ltd

 
 
CPD

Cambridge Positioning Systems pioneered non-GPS location systems based on technology developed at the Mullard Radioastronomy Laboratory. CPS was acquired by CSR plc in January 2007.

 
 
DeNovo

DeNovo Pharmaceuticals is a developer of computerised drug design systems.

 
 
Equitalk

Equitalk is a low cost web-based telephony provider. Equitalk was acquired by Xfone Inc in July 2006.

 
 
Oi! Bagel

Oi! Bagel operated delicatessan-style bagel outlets across Greater London. Oi! Bagel was acquired by GABF Holdings Ltd, trading as Bagel Factory, in August 2008.

 
 
Phico

Phico is a therapeutic biotechnology company developing treatments for multiply resistant bacteria

 
 
Signify

Signify is an authentication and identity management service provider. Signify was acquired by Accumuli plc in June 2013.

 
 
Plastic Logic

Plastic Logic develops and manufactures printable, flexible plastic semiconductors, exploiting technology developed at the Cavdendish Laboratory in the University of Cambridge.

 
 
Solcom

Solcom develops systems for controlling advanced medical processes, particularly nuclear medicine. QTP, a fund managed by ETCapital, sold its interest in Solcom in October 2008.

 
 
Spirogen

Spirogen develops complex molecules and a platform technology for antibody drug conjugation being utilised in innovative anti cancer therapies. Spirogen was acquired by AstraZeneca in November 2013.

 
 
Teraview

Teraview, a spin-out from the Toshiba Cambridge Laboratory, uses terahertz band light for advanced imaging applications including pharmaceutical manufacturing

 
ET Capital Limited  Cambridge  UK  Authorised and regulated by FCA